Head And Neck Cancers

A personalized approach to radiation therapy can maximize therapeutic effect across multiple cancer types, according to findings published in The Lancet Oncology.

The FDA granted breakthrough therapy designation to tipifarnib for treatment of certain patients with head and neck squamous cell carcinoma, according to the agent’s manufacturer.